—

BAKER BROS. ADVISORS LP

Q1 2026 13F Holdings

  • Location
    new york, NY
  • Num holdings

    84

  • Value ($000)

    $17,415,690

  • Date Filed
    05/15/2026
  • Form type
    13F-HR
  • CIK
    0001263508
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q1 2026 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
I
INCY

Incyte Corporation

COM
45337C102
$2.89B
17 %

30,744,412

B
BGNE

BeOne Medicines Ltd.

SPONSORED ADS
07725L102
$2.61B
15 %

8,799,053

I
INSM

Insmed Incorporated

COM PAR $.01
457669307
$1.21B
7 %

7,421,111

M
MDGL

Madrigal Pharmaceuticals, Inc.

COM
558868105
$1.12B
6 %

2,141,701

A
ACAD

ACADIA Pharmaceuticals Inc.

COM
004225108
$954.88M
6 %

42,896,690

R
RVMD

Revolution Medicines, Inc.

COM
76155X100
$929.26M
5 %

9,555,357

C
CELC

Celcuity Inc.

COM
15102K100
$903.51M
5 %

7,915,792

K
KOD

Kodiak Sciences Inc.

COM
50015M109
$759.32M
4 %

19,919,186

K
KYMR

Kymera Therapeutics, Inc.

COM
501575104
$721.06M
4 %

8,657,242

S
SMMT

Summit Therapeutics Inc.

COM
86627T108
$689.97M
4 %

36,391,063

Rows Per Page
10
  • 10
  • 50
  • 100
1 - 10 of 84